These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11451256)

  • 1. Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up.
    Alexander KP; Newby LK; Hellkamp AS; Harrington RA; Peterson ED; Kopecky S; Langer A; O'Gara P; O'Connor CM; Daly RN; Califf RM; Khan S; Fuster V
    J Am Coll Cardiol; 2001 Jul; 38(1):1-7. PubMed ID: 11451256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current use of unopposed estrogen and estrogen plus progestin and the risk of acute myocardial infarction among women with diabetes: the Northern California Kaiser Permanente Diabetes Registry, 1995-1998.
    Ferrara A; Quesenberry CP; Karter AJ; Njoroge CW; Jacobson AS; Selby JV;
    Circulation; 2003 Jan; 107(1):43-8. PubMed ID: 12515741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal hormone use in women with acute coronary syndromes.
    Parsons E; Newby LK; Bhapkar MV; Alexander KP; White HD; Shah SH; Bushnell CD; Califf RM;
    J Womens Health (Larchmt); 2004 Oct; 13(8):863-71. PubMed ID: 15671702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women.
    Psaty BM; Smith NL; Lemaitre RN; Vos HL; Heckbert SR; LaCroix AZ; Rosendaal FR
    JAMA; 2001 Feb; 285(7):906-13. PubMed ID: 11180734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial infarction risk and hormone replacement: differences between products.
    de Vries CS; Bromley SE; Farmer RD
    Maturitas; 2006 Feb; 53(3):343-50. PubMed ID: 16040209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal hormone replacement therapy: scientific review.
    Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
    JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study.
    Bretler DM; Hansen PR; Abildstrøm SZ; Jørgensen CH; Sørensen R; Hansen ML; Schramm TK; Løkkegaard E; Torp-Pedersen C; Gislason GH
    Br J Clin Pharmacol; 2011 Jan; 71(1):105-15. PubMed ID: 21143506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women.
    Angeja BG; Shlipak MG; Go AS; Johnston SC; Frederick PD; Canto JG; Barron HV; Grady D;
    J Am Coll Cardiol; 2001 Nov; 38(5):1297-301. PubMed ID: 11691498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women.
    Shlipak MG; Angeja BG; Go AS; Frederick PD; Canto JG; Grady D
    Circulation; 2001 Nov; 104(19):2300-4. PubMed ID: 11696469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
    Giustino G; Harari R; Baber U; Sartori S; Stone GW; Leon MB; Windecker S; Serruys PW; Kastrati A; Von Birgelen C; Kimura T; Stefanini GG; Dangas GD; Wijns W; Steg PG; Morice MC; Camenzind E; Weisz G; Smits PC; Sorrentino S; Sharma M; Farhan S; Faggioni M; Kandzari D; Galatius S; Jeger RV; Valgimigli M; Itchhaporia D; Mehta L; Kim HS; Chieffo A; Mehran R
    JAMA Cardiol; 2017 Aug; 2(8):855-862. PubMed ID: 28658478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal estrogens and risk of myocardial infarction in diabetic women.
    Kaplan RC; Heckbert SR; Weiss NS; Wahl PW; Smith NL; Newton KM; Psaty BM
    Diabetes Care; 1998 Jul; 21(7):1117-21. PubMed ID: 9653605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT).
    Sourander L; Rajala T; Räihä I; Mäkinen J; Erkkola R; Helenius H
    Lancet; 1998 Dec 19-26; 352(9145):1965-9. PubMed ID: 9872245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study.
    Clarke SC; Kelleher J; Lloyd-Jones H; Slack M; Schofiel PM
    BJOG; 2002 Sep; 109(9):1056-62. PubMed ID: 12269682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of cardiovascular outcomes in users of estradiol/dydrogesterone or other HRT preparations.
    Schneider C; Jick SS; Meier CR
    Climacteric; 2009 Oct; 12(5):445-53. PubMed ID: 19565370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary and secondary prevention of cardiovascular events through hormone replacement therapy (HRT)].
    Pilz H
    Wien Med Wochenschr; 2005 Sep; 155(17-18):397-403. PubMed ID: 16392437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy and the risk of subarachnoid hemorrhage in postmenopausal women.
    Qureshi AI; Malik AA; Saeed O; Defillo A; Sherr GT; Suri MF
    J Neurosurg; 2016 Jan; 124(1):45-50. PubMed ID: 26162033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. a prospective, observational study.
    Grodstein F; Manson JE; Stampfer MJ
    Ann Intern Med; 2001 Jul; 135(1):1-8. PubMed ID: 11434726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
    Grady D; Herrington D; Bittner V; Blumenthal R; Davidson M; Hlatky M; Hsia J; Hulley S; Herd A; Khan S; Newby LK; Waters D; Vittinghoff E; Wenger N;
    JAMA; 2002 Jul; 288(1):49-57. PubMed ID: 12090862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer and hormone-replacement therapy in the Million Women Study.
    Beral V;
    Lancet; 2003 Aug; 362(9382):419-27. PubMed ID: 12927427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.